GlassScriptPhysician profile
Robert C Janot
NPI 1891841342
$12,961.41
in general payments reported to CMS, 2019-2025
22 companies · $1,931 in 2025
The $1,931 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.54 · 2020: $402 · 2021: $2,548 · 2022: $1,175 · 2023: $3,698 · 2024: $3,138 · 2025: $1,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,717 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,860 · Entertainment: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,716.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,860.00 |
| Entertainment | $191.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,887.19 | 2023-2024 | Infuse, Biotrue, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,900.00 | 2021 | |
| Abbvie INC. | $933.67 | 2022-2025 | |
| Coopervision INC. | $932.90 | 2019-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Biotissue Holdings INC. | $857.18 | 2022-2025 | |
| Glaukos Corporation | $713.08 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Alcon Vision LLC | $616.38 | 2021-2025 | Total30, Precision7, Clareon Panoptix Pro |
| Optos, INC. | $479.02 | 2020-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $417.51 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $400.31 | 2022-2023 | Cirrus Hd-Oct, Clarus |
| Allergan, INC. | $377.26 | 2020-2022 | |
| Dompe US, INC. | $363.35 | 2023-2025 | Oxervate |
| Oyster Point Pharma, INC. | $241.13 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $239.44 | 2022-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $188.43 | 2023-2025 | Cequa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $155.67 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $65.64 | 2024-2025 | Tobradex St, Natacyn, Verkazia |
| Sight Sciences, INC. | $59.62 | 2025 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $48.11 | 2021-2022 | |
| Maculogix, INC. | $36.31 | 2019 | |
| Ocular Therapeutix, INC. | $28.84 | 2023 | Dextenza |
| Novartis Pharmaceuticals Corporation | $20.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Janot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.